[1] 朱雯,江洪涛,程小燕,等. TG/HDL-C结合CRP/Alb预测腹膜透析患者死亡风险的价值[J]. 中国现代医学杂志,2023,33(24):23-28.DOI:10.3969/j.issn.1005-8982. 2023.24.005.
[2] 陈铭聿,周丽君,李建中,等. 腹膜透析患者体质量指数与腹膜透析充分性的关系[J]. 中国现代医学杂志,2022,32(12):90-95.DOI:10.3969/j.issn.1005-8982.2022.12.016.
[3] 牛福坤,胡范玲,郭淑霞,等. 高压氧治疗对腹膜透析伴认知功能障碍患者疗效及生活质量的影响[J]. 中华航海医学与高气压医学杂志,2022,29(5):665-670.DOI:10.3760/cma.j.cn311847-20210306-00077.
[4] 王芸,周梅芳,陈斯霞,等. 腹膜透析患者主观认知下降现状及其与衰弱的相关性研究[J]. 军事护理,2023,40(8):49-52.DOI:10.3969/j.issn.2097-1826.2023.08.012.
[5] 万胜,朱虹,程力,等. 持续非卧床腹膜透析患者认知功能障碍及其危险因素分析[J]. 临床肾脏病杂志,2022,22(9):719-724.DOI:10.3969/j.issn.1671-2390.2022.09.003.
[6] 廖瑾岚,魏奇杰,何颖颖,等. 腹膜透析糖尿病患者眼底血管参数和认知功能评估的临床应用研究[J]. 实用临床医药杂志,2022,26(1):85-88.DOI:10.7619/jcmp.20213252.
[7] 钱玉珺,杨建萍,侯波,等. 维持性血液透析与腹膜透析患者认知功能障碍的比较[J]. 中华肾脏病杂志,2020,36(9):657-665.DOI:10.3760/cma.j.cn441217-20200303-00119.
[8] Drew DA, Weiner DE, Sarnak MJ. Cognitive impairment in CKD: pathophysiology, management, and prevention[J].Am J Kidney Dis,2019,74(6):782-790.DOI:10.1053/j.ajkd.2019.05.017.
[9] Cai H, Chen L. Advances in research related to cognitive impairment in maintenance hemodialysis patients[J].Academic Journal of Medicine & Health Sciences,2023,4(4):20-25.DOI:10.25236/AJMHS.2023.040404.
[10] Viggiano D, Wagner CA, Martino G, et al. Mechanisms of cognitive dysfunction in CKD[J].Nat Rev Nephrol,2020,16(8):452-469.DOI:10.1038/s41581-020-0266-9.
[11] Catarina Brás A, Marques J, Alves P, et al. MO691: risk factors associated with cognitive dysfunction in peritoneal dialysis[J].Nephrology Dialysis Transplantation,2022,37(Supplement_3):gfac078.028.DOI:10.1093/ndt/gfac078.028
[12] Huang X, Yi C, Wu M, et al. Risk factors and clinical outcomes of cognitive impairment in diabetic patients undergoing peritoneal dialysis[J].Kidney Blood Press Res,2021,46(5):531-540.DOI:10.1159/000514172.
[13] 姜子健,宋志伟,邹凌,等. 伴认知障碍终末期肾病维持性透析患者脑功能默认网络拓扑属性改变[J]. 中华行为医学与脑科学杂志,2022,31(3):229-234.DOI:10.3760/cma.j.cn371468-20210823-00482.
[14] Wu H, Zhou H, Zhang Q, et al. Systematic review and meta-analysis: the effect and safety of peritoneal dialysis in patients with end-stage diabetic kidney disease[J].Ann Palliat Med,2022,11(2):695-707.DOI:10.21037/apm-22-50.
[15] Khan SF, Ronco C, Rosner MH. Counteracting the metabolic effects of glucose load in peritoneal dialysis patients; an exercise-Based approach[J].Blood Purif,2019,48(1):25-31.DOI:10.1159/000499406.
[16] Liu S, Tang X, Li X, et al. Efficacy of continuous ambulatory peritoneal dialysis combined with hemodialysis versus single hemodialysis in patients with end-stage renal disease[J].Am J Transl Res,2021,13(9):10485-10492.
[17] 李昭,马莹,吕晶,等.细菌种类对腹膜透析相关性腹膜炎患者短期预后的影响[J].现代医院,2023,23(6):970-974,978.DOI:10.3969/j.issn.1671-332X.2023.06.039.
[18] Wu C, Yu R, Li Q, et al. Exploring the impact of cognitive impairments on treatment compliance and quality of life in patients with continuous ambulatory peritoneal dialysis (CAPD)[J].Medicine (Baltimore),2023,102(43):e35813.DOI:10.1097/MD.0000000000035813.
[19] Joseph SJ, Bhandari SS, Dutta S. Cognitive impairment and its correlates in chronic kidney disease patients undergoing haemodialysis[J].J Evol Med Dent Sci,2019,8(36):2818-2822.DOI:10.14260/jemds/2019/611.
[20] Thomas AG, Ruck JM, Shaffer AA, et al. Kidney transplant outcomes in recipients with cognitive impairment: a national registry and prospective cohort study[J].Transplantation,2019,103(7):1504-1513.DOI:10.1097/TP.0000000000002431.
[21] Shea YF, Lam MF, Lee MS, et al. Prevalence of cognitive impairment among peritoneal dialysis patients, impact on peritonitis and role of assisted dialysis[J].Perit Dial Int,2016,36(3):284-290.DOI:10.3747/pdi.2014.00247.
[22] Shea YF, Lee MC, Mok MM, et al. Prevalence of cognitive impairment among peritoneal dialysis patients: a systematic review and meta-analysis[J].Clin Exp Nephrol,2019,23(10):1221-1234.DOI:10.1007/s10157-019-01762-1.
[23] 段丽萍,郑朝霞,张宇慧,等. 腹膜透析患者营养不良-炎症-心血管疾病与认知功能恶化的关系[J]. 北京大学学报(医学版),2019,51(3):510-518.DOI:10.19723/j.issn.1671-167X.2019.03.020.
[24] Shea YF, Lee MC, Mok MM, et al. Self-care peritoneal dialysis patients with cognitive impairment have a higher risk of peritonitis in the second year[J].Perit Dial Int,2019,39(1):51-58.DOI:10.3747/pdi.2018.00048.
[25] Zhao Y, Zhang Y, Yang Z, et al. Sleep disorders and cognitive impairment in peritoneal dialysis: a multicenter prospective cohort Study[J].Kidney Blood Press Res,2019,44(5):1115-1127.DOI:10.1159/000502355.
[26] Salazar-Félix NA, Martin-Del-Campo F, Cueto-Manzano AM, et al. Prevalence of mild cognitive impairment in automated peritoneal dialysis patients[J].Nephrol Dial Transplant,2021,36(11):2106-2111.DOI:10.1093/ndt/gfab238.
[27] Ayed A, Ben salem M, Haouala F, et al. P1225 prevalence and prognostic significance of diabetes in peritoneal dialysis: technique and patient survival[J].Nephrology Dialysis Transplantation,2020,35(Supplement_3):gfaa142.P1225.DOI:10.1093/ndt/gfaa142.p1225.
[28] Shifris IM. Diabetic status, comorbidit y and survival in patients with chronic kidney dise ase stage VD st.: a cohort study[J]. Problems of endocrine pathology,2020,72(2): 95-103.DOI:10.21856/j-pep.2020.2.12.
[29] Doroodgar M, Doroodgar M, Tofangchiha S. Evaluation of relation between HbA1c level with cognitive disorders and depression in type 2 diabetes mellitus patients[J].Open Access Maced J Med Sci,2019,7(15):2462-2466.DOI:10.3889/oamjms.2019.658.
[30] Pappas C, Small BJ, Andel R, et al. Blood glucose levels may exacerbate executive function deficits in older adults with cognitive impairment[J].J Alzheimers Dis,2019,67(1):81-89.DOI:10.3233/JAD-180693.
[31] van Sloten TT, Sedaghat S, Carnethon MR, et al. Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression[J].Lancet Diabetes Endocrinol,2020,8(4):325-336.DOI:10.1016/S2213-8587(19)30405-X.
[32] Zhu HC, Tao Y, Li YM. Correlations of insulin resistance and HbA1c with cytokines IGF-1, bFGF and IL-6 in the aqueous humor of patients with diabetic cataract[J].Eur Rev Med Pharmacol Sci,2019,23(1):16-22.DOI:10.26355/eurrev_201901_16742.
[33] Miller RG, McGurnaghan SJ, Onengut-Gumuscu S, et al. Insulin resistance-associated genetic variants in type 1 diabetes[J].J Diabetes Complications,2021,35(4):107842.DOI:10.1016/j.jdiacomp.2020.107842.
[34] Yoon JH, Hwang J, Son SU, et al. How can insulin resistance cause alzheimer's disease?[J].Int J Mol Sci,2023,24(4):3506.DOI:10.3390/ijms24043506.
[35] Wang T, Xu SF, Fan YG, et al. Iron pathophysiology in alzheimer's diseases[J].Adv Exp Med Biol,2019,1173:67-104.DOI:10.1007/978-981-13-9589-5_5.
[36] Wang F, Wang J, Shen Y, et al. Iron dyshomeostasis and ferroptosis: a new alzheimer's disease hypothesis?[J].Front Aging Neurosci,2022,14:830569.DOI:10.3389/fnagi.2022.830569.
|